MESALAZINE

mesalazine 1.2 g modified release tablet, 60

MESALAZINE (13487W)

mesalazine 1.2 g modified release tablet, 60
13487W
Manner of administration:Oral
General Schedule
Restricted Benefit

Restriction

Indication: Ulcerative colitis
Quantities & Cost
Max qty packs Max qty units # of repeats DPMQ Max safety net General Patient Charge
Max qty packs: 4 Max qty units: 240 # of repeats: 5 DPMQ: $339.04 Max safety net: $25.00 General Patient Charge: $25.00
Available brands
MEZTAS
Mesalazine 1.2 TAKEDA
Mezavant